Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01538472
What this trial is testing

Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 40
Early research (Phase 1)WithdrawnNCT03369964
What this trial is testing

Atezolizumab in Combination With an Immunotherapy Agent Investigated With or Without Anti-Cd20 Therapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Hoffmann-La Roche
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07825389
What this trial is testing

C-CAR168 in Participants With Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AbelZeta Inc. 119
Early research (Phase 1)Looking for participantsNCT06351527
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies

Who this might be right for
Mature B-cell Malignancies
InnoCare Pharma Inc. 78
Not applicableLooking for participantsNCT07343089
What this trial is testing

Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France

Who this might be right for
Borrelia Infections
University Hospital, Strasbourg, France 100
Large-scale testing (Phase 3)Study completedNCT00004179
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 475
Not applicableUnknownNCT04640818
What this trial is testing

Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy

Who this might be right for
Multiple Sclerosis
Claudio Gobbi 45
Large-scale testing (Phase 3)UnknownNCT03777085
What this trial is testing

Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 230
Large-scale testing (Phase 3)Not Yet RecruitingNCT07472413
What this trial is testing

Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project

Who this might be right for
Multiple Sclerosis
University of Miami 60
Testing effectiveness (Phase 2)Study completedNCT01788189
What this trial is testing

Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas

Who this might be right for
B-cell Lymphoma
University Hospital, Essen 37
Large-scale testing (Phase 3)Ended earlyNCT00406419
What this trial is testing

Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE)

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 1,015
Post-approval studies (Phase 4)Not Yet RecruitingNCT07818356
What this trial is testing

Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

Who this might be right for
VaccineVaricella-zoster VirusMultiple Sclerosis+1 more
University Hospital, Toulouse 160
Large-scale testing (Phase 3)Study completedNCT00012051
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Commissie Voor Klinisch Toegepast Onderzoek 340
Early research (Phase 1)Study completedNCT00434629
What this trial is testing

Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant

Who this might be right for
B-cell LymphomaNon-Hodgkin's Lymphoma
University of Pennsylvania 16
Testing effectiveness (Phase 2)Study completedNCT00080886
What this trial is testing

Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT05453435
What this trial is testing

Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody)

Who this might be right for
Resolved Hepatitis BCD20 Positive B-cell Lymphoma
Sun Yat-sen University 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT07044115
What this trial is testing

Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis

Who this might be right for
Lupus Nephritis
Beijing Mabworks Biotech Co., Ltd. 41
Testing effectiveness (Phase 2)Ended earlyNCT05660967
What this trial is testing

Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Genmab 111
Large-scale testing (Phase 3)Study completedNCT00577993
What this trial is testing

Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 210
Early research (Phase 1)Study completedNCT03019055
What this trial is testing

Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, B-CellChronic Lymphocytic Leukemia+1 more
Medical College of Wisconsin 26
Next Page